热门资讯> 正文
ARCA BIGUMA股价下跌，CEO离职
2024-04-05 21:06
- ARCA Biopharma (NASDAQ:ABIO) shares down about 7% premarket after company and CEO Michael Bristow mutually agreed to conclude Bristow’s employment and service as a director, effective April 3.
- Effective as of April 3, the Board appointed Thomas A. Keuer, the company’s Chief Operating Officer, to serve as ARCA’s President and principal executive officer.
- SEC Filing
More on ARCA biopharma
- ARCA biopharma to merge with Oruka Therapeutics in all-stock transaction
- Financial information for ARCA biopharma
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
